Journal of Vaccine Research 2024, Vol.14, No.4, 207-216 http://medscipublisher.com/index.php/jvr 216 Maslow J.N., 2019, Challenges and solutions in the development of vaccines against emerging and neglected infectious diseases, Human Vaccines and Immunotherapeutics, 15(10): 2230-2234. https://doi.org/10.1080/21645515.2019.1661209 PMid:31644396 PMCid:PMC6816441 Mba I., Sharndama H., Anyaegbunam Z., Anekpo C., Amadi B., Morumda D., Doowuese Y., Ihezuo U., Chukwukelu J., and Okeke O.P., 2023, Vaccine development for bacterial pathogens: Advances, challenges and prospects, Tropical Medicine and International Health, 28(4): 275-299. https://doi.org/10.1111/tmi.13865 PMid:36861882 Ojha R., Singh S., Gupta N., Kumar K., Padhi A.K., and Prajapati V.K., 2023, Multi-pathogen based chimeric vaccine to fight against COVID-19 and concomitant coinfections, Biotechnology Letters, 45(7): 779-797. https://doi.org/10.1007/s10529-023-03380-0 PMid:37148345 PMCid:PMC10163573 Pulendran B., Arunachalam P.S., and O'Hagan D.T., 2021, Emerging concepts in the science of vaccine adjuvants, Nature Reviews Drug Discovery, 20(6): 454-475. https://doi.org/10.1038/s41573-021-00163-y PMid:33824489 PMCid:PMC8023785 Rauch S., Jasny E., Schmidt K., and Petsch B., 2018, New vaccine technologies to combat outbreak situations, Frontiers in Immunology, 9, 1963. https://doi.org/10.3389/fimmu.2018.01963 PMid:30283434 PMCid:PMC6156540 Tognetti F., Biagini M., Denis M., Berti F., Maione D., and Stranges D., 2023, Evolution of Vaccines Formulation to Tackle the Challenge of Anti-Microbial Resistant Pathogens, International Journal of Molecular Sciences, 24(15): 12054. https://doi.org/10.3390/ijms241512054 PMid:37569427 PMCid:PMC10418901 Wang W., and Huang Q.K., 2024, The application prospects of artificial intelligence in molecular medicine, International Journal of Molecular Medical Science, 14(1): 16-23. https://doi.org/10.5376/ijmms.2024.14.0003 Yenkoidiok-Douti L., and Jewell C.M., 2020, Integrating biomaterials and immunology to improve vaccines against infectious diseases, ACS Biomaterials Science and Engineering, 6(2): 759-778. https://doi.org/10.1021/acsbiomaterials.9b01255 PMid:33313391 PMCid:PMC7725244 Zaman M., Huber V.C., Heiden D.L., DeHaan K.N., Chandra S., Erickson D., Ozberk V., Pandey M., Bailly B., Martin G., Langshaw E.L., Zaid A., von Itzstein M., and Good M.F., 2021, Combinatorial liposomal peptide vaccine induces IgA and confers protection against influenza virus and bacterial super‐infection, Clinical and Translational Immunology, 10(9): e1337. https://doi.org/10.1002/cti2.1337 PMid:34527244 PMCid:PMC8432089 Zhang J., 2024, From genomic data to personalized medical decisions: challenges and opportunities, International Journal of Clinical Case Reports, 14(2): 107-116. https://doi.org/10.5376/ijccr.2024.14.0013 Zhao T., Cai Y., Jiang Y., He X., Wei Y., Yu Y., and Tian X., 2023, Vaccine adjuvants: mechanisms and platforms, Signal Transduction and Targeted Therapy, 8(1): 283. https://doi.org/10.1038/s41392-023-01557-7 PMid:37468460 PMCid:PMC10356842 Zhou X., Jiang X., Qu M., Aninwene G., Jucaud V., Moon J., Gu Z., Sun W., and Khademhosseini A., 2020, Engineering antiviral vaccines, ACS Nano, 14(10): 12370-12389. https://doi.org/10.1021/acsnano.0c06109 PMid:33001626 PMCid:PMC7534801
RkJQdWJsaXNoZXIy MjQ4ODYzNQ==